Enzyme-Responsive Double-Locked Photodynamic Molecular Beacon for Targeted Photodynamic Anticancer Therapy

Overview

Journal J Am Chem Soc

Publisher American Chemical Society

Specialty Chemistry

Date 2023 Mar 24

PMID 36961946

Authors

Leo K B Tam

Jacky C H Chu

Lin He

Caixia Yang

Kam-Chu Han

Peter Chi Keung Cheung

Dennis K P Ng

Pui-Chi Lo

Affiliations

Soon will be listed here.

Abstract

An advanced photodynamic molecular beacon (PMB) was designed and synthesized, in which a distyryl boron dipyrromethene (DSBDP)-based photosensitizer and a Black Hole Quencher 3 moiety were connected via two peptide segments containing the sequences PLGVR and GFLG, respectively, of a cyclic peptide. These two short peptide sequences are well-known substrates of matrix metalloproteinase-2 (MMP-2) and cathepsin B, respectively, both of which are overexpressed in a wide range of cancer cells either extracellularly (for MMP-2) or intracellularly (for cathepsin B). Owing to the efficient Förster resonance energy transfer between the two components, this PMB was fully quenched in the native form. Only upon interaction with both MMP-2 and cathepsin B, either in a buffer solution or in cancer cells, both of the segments were cleaved specifically, and the two components could be completely separated, thereby restoring the photodynamic activities of the DSBDP moiety. This PMB could also be activated in tumors, and it effectively suppressed the tumor growth in A549 tumor-bearing nude mice upon laser irradiation without causing notable side effects. In particular, it did not cause skin photosensitivity, which is a very common side effect of photodynamic therapy (PDT) using conventional "always-on" photosensitizers. The overall results showed that this "double-locked" PMB functioned as a biological AND logic gate that could only be unlocked by the coexistence of two tumor-associated enzymes, which could greatly enhance the tumor specificity in PDT.

Citing Articles

Ratiometric surface-enhanced Raman scattering quantification of extracellular matrix metalloproteinase-2 activity for tumor diagnosis.

Zhu D, Zhong H, Shi J, Liu Q, Wang Y Anal Bioanal Chem. 2025; .

PMID: 39966175 DOI: 10.1007/s00216-025-05792-5.

Constructing Activatable Photosensitizers Using Covalently Modified Mesoporous Silica.

Liu Y, Wang X, Wang B, Lu Z, Wu C, He Z Adv Sci (Weinh). 2025; 12(9):e2406887.

PMID: 39812217 PMC: 11884586. DOI: 10.1002/advs.202406887.

A hypoxia-activated and microenvironment-remodeling nanoplatform for multifunctional imaging and potentiated immunotherapy of cancer.

Song J, Wang H, Meng X, Li W, Qi J Nat Commun. 2024; 15(1):10395.

PMID: 39613774 PMC: 11607447. DOI: 10.1038/s41467-024-53906-x.

Organelle-Specific Smart Supramolecular Materials for Bioimaging and Theranostics Application.

Bharathidasan D, Maity C Top Curr Chem (Cham). 2024; 383(1):1.

PMID: 39607460 DOI: 10.1007/s41061-024-00483-8.

Smart molecular designs and applications of activatable organic photosensitizers.

Nestoros E, Sharma A, Kim E, Kim J, Vendrell M Nat Rev Chem. 2024; 9(1):46-60.

PMID: 39506088 DOI: 10.1038/s41570-024-00662-7.

References

Cheng P, Pu K . Activatable Phototheranostic Materials for Imaging-Guided Cancer Therapy. ACS Appl Mater Interfaces. 2019; 12(5):5286-5299. DOI: 10.1021/acsami.9b15064. View

Lau J, Lo P, Jiang X, Wang Q, K P Ng D . A dual activatable photosensitizer toward targeted photodynamic therapy. J Med Chem. 2014; 57(10):4088-97. DOI: 10.1021/jm500456e. View

Yoon M, Christy M, Phan V, Gerwick W, Hook G, ODonoghue A . Molecular Features of CA-074 pH-Dependent Inhibition of Cathepsin B. Biochemistry. 2022; 61(4):228-238. PMC: 9096814. DOI: 10.1021/acs.biochem.1c00684. View

Ke M, K P Ng D, Lo P . Synthesis and in vitro photodynamic activities of an integrin-targeting cRGD-conjugated zinc(II) phthalocyanine. Chem Asian J. 2013; 9(2):554-61. DOI: 10.1002/asia.201301166. View

Chu J, Yang C, Fong W, Wong C, K P Ng D . Facile one-pot synthesis of cyclic peptide-conjugated photosensitisers for targeted photodynamic therapy. Chem Commun (Camb). 2020; 56(80):11941-11944. DOI: 10.1039/d0cc05264g. View

Mishchenko T, Balalaeva I, Gorokhova A, Vedunova M, Krysko D . Which cell death modality wins the contest for photodynamic therapy of cancer?. Cell Death Dis. 2022; 13(5):455. PMC: 9106666. DOI: 10.1038/s41419-022-04851-4. View

Lucky S, Soo K, Zhang Y . Nanoparticles in photodynamic therapy. Chem Rev. 2015; 115(4):1990-2042. DOI: 10.1021/cr5004198. View

Henriet P, Emonard H . Matrix metalloproteinase-2: Not (just) a "hero" of the past. Biochimie. 2019; 166:223-232. DOI: 10.1016/j.biochi.2019.07.019. View

Zhang N, Zhao F, Zou Q, Li Y, Ma G, Yan X . Multitriggered Tumor-Responsive Drug Delivery Vehicles Based on Protein and Polypeptide Coassembly for Enhanced Photodynamic Tumor Ablation. Small. 2016; 12(43):5936-5943. DOI: 10.1002/smll.201602339. View

10.

Tam L, Yu L, Wong R, Fong W, K P Ng D, Lo P . Dual Cathepsin B and Glutathione-Activated Dimeric and Trimeric Phthalocyanine-Based Photodynamic Molecular Beacons for Targeted Photodynamic Therapy. J Med Chem. 2021; 64(23):17455-17467. DOI: 10.1021/acs.jmedchem.1c01634. View

11.

Zhao H, Li L, Zheng C, Hao Y, Niu M, Hu Y . An intelligent dual stimuli-responsive photosensitizer delivery system with O-supplying for efficient photodynamic therapy. Colloids Surf B Biointerfaces. 2018; 167:299-309. DOI: 10.1016/j.colsurfb.2018.04.011. View

12.

Lee D, Kwon S, Jang S, Park E, Lee Y, Koo H . Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles. Bioact Mater. 2021; 8:20-34. PMC: 8424083. DOI: 10.1016/j.bioactmat.2021.06.019. View

13.

Entradas T, Waldron S, Volk M . The detection sensitivity of commonly used singlet oxygen probes in aqueous environments. J Photochem Photobiol B. 2020; 204:111787. DOI: 10.1016/j.jphotobiol.2020.111787. View

14.

Zheng X, Sun W, Ju M, Wu J, Huang H, Shen B . A chemical biology toolbox to overcome the hypoxic tumor microenvironment for photodynamic therapy: a review. Biomater Sci. 2022; 10(17):4681-4693. DOI: 10.1039/d2bm00776b. View

15.

Sun B, Rahmat J, Zhang Y . Advanced techniques for performing photodynamic therapy in deep-seated tissues. Biomaterials. 2022; 291:121875. DOI: 10.1016/j.biomaterials.2022.121875. View

16.

Li M, Xu Y, Peng X, Kim J . From Low to No O-Dependent Hypoxia Photodynamic Therapy (hPDT): A New Perspective. Acc Chem Res. 2022; 55(22):3253-3264. DOI: 10.1021/acs.accounts.2c00531. View

17.

Tam L, He L, K P Ng D, Cheung P, Lo P . A Tumor-Targeting Dual-Stimuli-Activatable Photodynamic Molecular Beacon for Precise Photodynamic Therapy. Chemistry. 2022; 28(57):e202201652. DOI: 10.1002/chem.202201652. View

18.

Pham T, Nguyen V, Choi Y, Lee S, Yoon J . Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy. Chem Rev. 2021; 121(21):13454-13619. DOI: 10.1021/acs.chemrev.1c00381. View

19.

Castano A, Mroz P, Hamblin M . Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer. 2006; 6(7):535-45. PMC: 2933780. DOI: 10.1038/nrc1894. View

20.

Hong L, Li J, Luo Y, Guo T, Zhang C, Ou S . Recent Advances in Strategies for Addressing Hypoxia in Tumor Photodynamic Therapy. Biomolecules. 2022; 12(1). PMC: 8774200. DOI: 10.3390/biom12010081. View